Skip to main content

Summit Financial, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1765536 PARSIPPANY, NJ

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,722,290
+$2,854,704 QoQ
Shares Held
16,466
+28.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Summit Financial, LLC holds $36,813,099 across 19 Biotechnology names. REGN ranks #1 (34.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
16,466 $12,722,290

All Filings in REGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,722,290 16,466
2025-12-31 $9,867,586 12,784
2025-09-30 $7,164,444 12,742
2025-06-30 $4,625,250 8,810
2025-03-31 $6,720,301 10,596
2024-12-31 $7,502,259 10,532
2024-09-30 $13,436,949 12,782
2024-06-30 $8,591,119 8,174
2024-03-31 $7,017,514 7,291
2023-12-31 $7,033,346 8,008
2023-09-30 $5,232,379 6,358
2023-06-30 $4,914,813 6,840